Search research articles
Contact Us
Filters
Showing results (171-180 of 179) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 179 results.
Nature Communications
|
July 19, 2018
Stromal PTEN determines mammary epithelial response to radiotherapy
Gina M Sizemore, Subhasree Balakrishnan, Katie A Thies, et al.
NPJ Precision Oncology
|
July 3, 2025
Prevalence and biological impact of clinically relevant gene fusions in head and neck cancers
Emily L Hoskins, Raven Vella, Julie W Reeser, et al.
Research Square
|
February 23, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22
Sumithira Vasu, Nathan Denlinger, No-Joon Song, et al.
Blood Cancer Discovery
|
July 14, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22
Sumithira Vasu, Nathan Denlinger, No-Joon Song, et al.
Blood Cancer Discovery
|
November 5, 2025
PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic Leukemia
Britten K Gordon, Elizabeth M Muhowski, Jyotsana Singh, et al.
Life Science Alliance
|
November 21, 2018
Disruption of stromal hedgehog signaling initiates RNF5-mediated proteasomal degradation of PTEN and accelerates pancreatic tumor growth
Jason R Pitarresi, Xin Liu, Alex Avendano, et al.
Genes & Development
|
August 26, 2015
Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo
Enrico Caserta, Onur Egriboz, Hui Wang, et al.
Nature Communications
|
January 7, 2023
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation
Zachary A Hing, Janek S Walker, Ethan C Whipp, et al.
Cancer Discovery
|
February 2, 2018
BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor
Hatice Gulcin Ozer, Dalia El-Gamal, Ben Powell, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 179) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 179 results.
Nature Communications
|
July 19, 2018
Stromal PTEN determines mammary epithelial response to radiotherapy
Gina M Sizemore, Subhasree Balakrishnan, Katie A Thies, et al.
NPJ Precision Oncology
|
July 3, 2025
Prevalence and biological impact of clinically relevant gene fusions in head and neck cancers
Emily L Hoskins, Raven Vella, Julie W Reeser, et al.
Research Square
|
February 23, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22
Sumithira Vasu, Nathan Denlinger, No-Joon Song, et al.
Blood Cancer Discovery
|
July 14, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22
Sumithira Vasu, Nathan Denlinger, No-Joon Song, et al.
Blood Cancer Discovery
|
November 5, 2025
PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic Leukemia
Britten K Gordon, Elizabeth M Muhowski, Jyotsana Singh, et al.
Life Science Alliance
|
November 21, 2018
Disruption of stromal hedgehog signaling initiates RNF5-mediated proteasomal degradation of PTEN and accelerates pancreatic tumor growth
Jason R Pitarresi, Xin Liu, Alex Avendano, et al.
Genes & Development
|
August 26, 2015
Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo
Enrico Caserta, Onur Egriboz, Hui Wang, et al.
Nature Communications
|
January 7, 2023
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation
Zachary A Hing, Janek S Walker, Ethan C Whipp, et al.
Cancer Discovery
|
February 2, 2018
BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor
Hatice Gulcin Ozer, Dalia El-Gamal, Ben Powell, et al.
Page
of 18